- Home
- / Neos Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Neos Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2021-03-25
Market Capitalization
$57.2 M
2021-03-25
Revenue
$64.6 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
| Revenue | 25.0M | 50.0M | 64.6M |
| Revenue growth, % | 99.8% | 29.3% | |
| Cost of goods sold | 12.4M | 26.9M | 25.1M |
| Gross profit | 12.6M | 23.1M | 39.5M |
| Gross profit margin, % | 50.5% | 46.1% | 61.1% |
| General and administrative expense | 13.8M | 13.9M | 13.2M |
| Operating expense total | 69.6M | 66.6M | 49.9M |
| EBIT | (57.0M) | (43.5M) | (10.4M) |
| EBIT margin, % | -227.9% | -87.0% | -16.1% |
| Interest expense | 10.1M | 9.0M | 8.0M |
| Pre tax profit | (16.9M) | ||
| Income tax expense | 11.0K | ||
| Net Income | (66.2M) | (51.7M) | (16.9M) |
| EPS | (2.7) | (1.6) | (0.3) |